Skip to main content

Table 3 gpt MF in the distal colon of untreated or DSS-treated Polk+/+ and Polk−/− female mice

From: DNA polymerase κ suppresses inflammation and inflammation-induced mutagenesis and carcinogenic potential in the colon of mice

Group

Genotype

 

Total population

Confirmed mutantsa

Mutant Frequency (× 10–6)

Mutant Frequency (× 10–6) (average ± S.D.)

Sequenced mutants

Corrected mutantsa

M Fa (× 10–6)

M F (× 10–6) (average ± S.D.)

3

Polk+/+

0

990,000

4

4.04

5.2 ± 1.8

4

2

2.0

4.4 ± 2.0

0

1,344,000

5

3.72

5

5

3.7

0

786,000

4

5.09

4

4

5.1

0

900,000

7

7.78

7

6

6.7

4

Polk+/+

2

1,674,000

5

2.99

5.3 ± 3.0

5

5

3.0

4.0 ± 1.5

2

816,000

2

2.45

2

2

2.5

2

960,000

8

8.33

7

5

5.2

2

966,000

7

7.25

7

5

5.2

7

Polk−/−

0

2,940,000

27

9.18

6.8 ± 4.1

25

18

6.1

5.2 ± 3.0

0

792,000

3

3.79

3

2

2.5

0

1,014,000

3

2.96

3

3

3.0

0

1,668,000

19

11.39

19

15

9.0

8

Polk−/−

2

1,440,000

35

24.31

17.8 ± 12.3

34

15

10.4

10.3 ± 6.3

2

1,566,000

16

10.22

15

15

9.6

2

984,000

31

31.50

31

18

18.3

2

3,762,000

19

5.05

19

11

2.9

  1. aGenomic DNA was extracted from distal portion of the large intestine of Polκ+/+ and Polκ−/− female mice and subjected to gpt assays. Initially isolated gpt mutants were confirmed by streaking them on agar plates containing 6-TG. Then, the "confirmed mutants" were subjected to DNA sequencing. When the mutations were identified, they were classified as "corrected mutants". "MF" was calculated by dividing the number of "corrected mutants" by the number of "total population"